Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Mar;100(3):315-23.
doi: 10.3324/haematol.2014.107706. Epub 2014 Nov 25.

Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood

Affiliations
Clinical Trial

Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood

Anna M Aalbers et al. Haematologica. 2015 Mar.

Abstract

Refractory cytopenia of childhood is the most common type of childhood myelodysplastic syndrome. Because the majority of children with refractory cytopenia have a normal karyotype and a hypocellular bone marrow, differentiating refractory cytopenia from the immune-mediated bone marrow failure syndrome (very) severe aplastic anemia can be challenging. Flow cytometric immunophenotyping of bone marrow has been shown to be a valuable diagnostic tool in differentiating myelodysplastic syndrome from non-clonal cytopenias in adults. Here, we performed the first comprehensive flow cytometric analysis of immature myeloid, lymphoid cells and erythroid cells, and granulocytes, monocytes, and lymphoid cells in bone marrow obtained from a large prospective cohort of 81 children with refractory cytopenia. Children with refractory cyotopenia had a strongly reduced myeloid compartment, but not as severe as children with aplastic anemia. Furthermore, the number of flow cytometric abnormalities was significantly higher in children with refractory cytopenia than in healthy controls and in children with aplastic anemia, but lower than in advanced myelodysplastic syndrome. We conclude that flow cytometric immunophenotyping could be a relevant addition to histopathology in the diagnosis of refractory cytopenia of childhood. (The multi-center studies EWOG-MDS RC06 and EWOG-MDS 2006 are registered at clinicaltrials.gov identifiers 00499070 and 00662090, respectively).

Trial registration: ClinicalTrials.gov NCT00499070 NCT00662090.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Cellular composition of bone marrow in refractory cytopenia of childhood patients and controls. For graphical representation, means of the main cell populations were calculated per patient and control group, and scaled to 100%. Precursors consist of myeloid blast cells and CD34+ B-cell precursors. NBM: normal bone marrow.
Figure 2.
Figure 2.
Immunophenotype of immature erythroid cell, granulocytes, and monocytes in refractory cytopenia of childhood patients and controls. (A) Normal expression of CD71 in healthy control bone marrow, ID NBM 023. (B) Heterogeneous CD71 expression in RCC patient, ID CH028. (C) Heterogeneous CD71 expression in RCC patient, ID I 220. (D) Normal pattern of CD16-CD13 expression in healthy control bone marrow, ID NBM 023. (E) Abnormal pattern of CD16-CD13 expression in RCC patient, ID D 663. (F) Abnormal pattern of CD16-CD13 expression in RCC patient, ID D 555. (G) Absence or low level of CD56 expression on monocytes, indicated in orange, in healthy control bone marrow, ID NBM 023. Granulocytes and lymphocytes are indicated in pink and green, respectively. (H) Aberrant expression (>20%) of CD56 on monocytes in RCC patient, ID CZ078. (I) Aberrant expression (>20%) of CD56 on monocytes in RCC patient, ID SC126. Pink and orange lines indicate reference image of normal granulocytes and monocytes, respectively.
Figure 3.
Figure 3.
Number of flow cytometric abnormalities in refractory cytopenia of childhood patients and controls. Lines indicate medians. Boxes extend from the 25th to 75th percentile; lines in the boxes indicate medians, whiskers indicate minimum and maximum values. **P<0.01; ****P<0.0001. NBM: normal bone marrow.

References

    1. Hasle H, Kerndrup G, Jacobsen BB. Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. Leukemia. 1995;9(9):1569–1572. - PubMed
    1. Hasle H, Wadsworth LD, Massing BG, McBride M, Schultz KR. A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada. Br J Haematol. 1999;106(4):1027–1032. - PubMed
    1. Passmore SJ, Chessells JM, Kempski H, Hann IM, Brownbill PA, Stiller CA. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival. Br J Haematol. 2003; 121(5):758–767. - PubMed
    1. Baumann I, Niemeyer CM, Bennett JM, Shannon K. Childhood myelodysplastic syndromes. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008:104–107.
    1. Baumann I, Fuhrer M, Behrendt S, et al. Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria. Histopathology. 2012;61(1):10–17. - PubMed

Publication types

MeSH terms

Associated data